Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
13.34
+0.13 (0.98%)
At close: Aug 31, 2026, 4:00 PM EDT
13.28
-0.06 (-0.45%)
Pre-market: Sep 1, 2026, 4:44 AM EDT

SLS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----17.6
Revenue Growth
-----86.84%300.00%
Cost of Revenue
----0.10.2
Gross Profit
----0.97.4
Selling, General & Admin
12.7711.1512.4213.8612.5811.32
Research & Development
20.3516.0219.124.0120.2715.67
Operating Expenses
33.1227.1731.5137.8732.8526.99
Operating Income
-33.12-27.17-31.51-37.87-31.95-19.59
Interest & Investment Income
2.761.410.630.530.320.01
Other Non Operating Income (Expenses)
---00.040.02
EBT Excluding Unusual Items
-30.36-25.76-30.88-37.34-31.6-19.57
Other Unusual Items
-1.1-1.1--0.34.34
Pretax Income
-32.46-26.86-30.88-37.34-41.3-20.94
Income Tax Expense
------0.24
Net Income
-32.46-26.86-30.88-37.34-41.3-20.7
Net Income to Common
-32.46-26.86-30.88-37.34-41.3-20.7
Net Income Growth
------
Shares Outstanding (Basic)
15310961281915
Shares Outstanding (Diluted)
15310961281915
Shares Change
86.04%78.18%120.33%43.21%25.29%94.07%
EPS (Basic)
-0.21-0.25-0.50-1.34-2.13-1.34
EPS (Diluted)
-0.21-0.25-0.50-1.34-2.13-1.34
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Per Share
-0.19-0.26-0.58-1.13-1.23-1.68
Gross Margin
----90.00%97.37%
Operating Margin
-----3195.00%-257.82%
Profit Margin
-----4130.10%-272.36%
Free Cash Flow Margin
-----2380.90%-342.38%
EBIT
-33.12-27.17-31.51-37.87-31.95-19.59
EBIT Margin
------257.82%
SEC Filings: 10-K · 10-Q